News
Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board
CHICAGO, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added Tom Kolefas to its Advisory Board. Kolefas brings more than 25 years of Wall Street experience on the buyside - managing both mutual fund and institutional equities at TIAA Investments, Jennison Associates, Loomis Sayles, Mackay-Shields and Bank of New York; as well as industry experience as a chemical engineer and corporate development officer at Engelhard/BASF. The Company ...
Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
Cosmos Holdings acquires Cosmofarm Cosmos Holdings, Inc. (OTCQB: COSM) announced the closing of its acquisition of Cosmofarm Ltd, a privately held fully licensed pharmaceutical wholesale company located in Athens, Greece. Founded in 1994, Cosmofarm is a fully licensed pharmaceutical wholesale company operating in the greater Athens area. The company is approved and authorized by the National Organization for Medicines under Good Distribution Practices to distribute a comprehensive range of pharmaceutical products. Cosmofarm’s core activity is sourcing, procuring and distributing branded and generic ...
Cosmos Holdings, Inc. Announces Third Quarter 2018 Results
Financial Highlights Operating revenues were $29.3 million for the nine months ended September 30, 2018, a 48% increase, as compared to $19.8 million for the same period the prior year. For the three months ended September 30, 2018, the gross profit margin increased to 9.3% from 8.1% for the same period in 2017. For the nine months ...
Cosmos Holdings, Inc. Adds Distinguished Member to Its Advisory Board to Fuel International Growth
CHICAGO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added a new member to its advisory board. Mr. Anastasios Tzikas is the president of several organizations including: Thessaloniki International Fair HELEXPO SA, Federation of Hellenic Information Technology & Communications (SEPE), and Technopolis Thessaloniki ICT Business Park. He is also one of the founders & former CEO of Singular Northern Greece SA, one of the largest software ...
Cosmos Holdings, Inc. Welcomes Dr. Ioannis Dedes MD to Its Advisory Board
CHICAGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added to its advisory board - Dr. Ioannis Dedes, MD an Interventional Radiologist and Interventional Oncologist. Dr. Dedes is a founding member of the Society of Interventional Oncology (SIO), and Director of Endovascular Interventional Radiology Department at Interbalkan European Medical Center located in Thessaloniki, Greece. “Dr. Ioannis Dedes brings a wealth of experience to our group,” said Grigorios ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo